新股暗盤 | 捷隆控股(1425.HK)暗盤段大漲逾20%
格隆匯11月27日丨捷隆控股(1425.HK)暗盤段大漲,現報0.49港元,較發行價0.4港元漲22.5%。公司主要從事OEM服裝製造業務,專門生產睡衣及家居便服產品,2016年至2018年收益分別為4.67億、5.24億、6.08億港元;溢利分別為4579.9萬、5141.1萬、4222.5萬港元;2018歷史市盈率11.84-14.80倍。公司此次全球發售3.125億股,其中國際發售2.81億股,香港發售3125萬股,每手5000股,淨籌6900萬港元;香港公開發售獲13.96倍認購。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.